Brief: Xeris Biopharma Q2 Net Income USD -19.842 Million
Aug 08 (Reuters) - Xeris Biopharma Q2 operating income USD -15.979 million. * Q2 basic EPS USD -0.14 * Q2 product revenue USD 36.893 million
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest